Replies to post #33155 on Regen BioPharma Inc (RGBP)

[Goldstrike]

What does your intern say?

[skichic]

I don’t know. Just went back and skimmed all the articles from 2014. The problem with BioParma companies is trials take a lot of time. First you have to get FDA approval to start a trial, usually they make you start with animals, then you can do humans. From start of research to finished marketable product in the cancer drug world could take 5 to 10 years. That’s a big problem. But for investors it can be a BIG payday. RGBP seems to have a lot in the works. I am patient.